DIRS.INFO The most relevant business & tech news

☆ MDMA therapy could be legalized by summer. Why are so many advocates sounding the alarm?
▼ + stars: | 2024-05-13 | by ( Anna Silman | ) www.businessinsider.com time to read: +52 min

Last summer, thousands of tie-dyed Burners and Patagonia-clad tech founders converged on the MAPS Psychedelic Science conference in Denver. The experience "broke the spell of this trauma, and she was able to rebuild her life," Doblin told The Guardian . The video team's job was to store recordings of every MDMA therapy session performed in the clinical trials. Grof believes in something called an "inner healing intelligence," an innate capacity for self-healing that psychedelic therapy helps unleash. Another time, a patient who had come to an MDMA therapy session later acknowledged they had been under the influence of LSD during treatment.

Persons: Jaden Smith, Aaron Rodgers, bro, Andrew Huberman, Rick Doblin, Doblin, mainstreaming psychedelics, influencers, Johnson, Elizabeth Nielson, Aubrey Marcus, ayahuasca, Matthew Stockman, Helena —, Timothy Leary, —, Hitler, Stanislav Grof, zombified, Brad Burge, Michael Mithoefer, Annie Mithoefer, Oprah, Sen, Joe Biden, MDMA's neurotoxicity, they'd, Albert Hofmann, David Bronner, Dr, Joe's, Bronner, Bronner's, Richard Rockefeller, John D, Rockefeller Jr, Rockefeller, Neşe, Johns Hopkins, who's, Devenot, Rick Friedman, Betty Aldworth, MAPS's multimillionaire, Tim Ferriss, Cody Swift, Zendo, Aldworth, Erica Siegal, Seth Whitelaw, Amy Emerson, JULIE JAMMOT, Ifetayo Harvey, Harvey, Lauren Unger, Unger, Casey Hardison, Harvey didn't, Hardison, Doblin's, Baylee Ybarra Gatlin, Gatlin, negligently, There's, Michael Pollan's, Steve Jurvetson, Elon Musk's who's, Genevieve, Steve Cohen, Alexandra, Mark Zuckerberg's, Dustin Moskovitz, Cari, Gwyneth Paltrow, Paltrow, Sergey Brin, Joe Green, Green, Zuckerberg, Genevieve Jurvetson, Michael Pollan, Jonathan Lubecky, he'd, Rebekah, Robert Mercer, Elizabeth Koch, Charles Koch, Rachel Nuwer, Koch, she'd, MAPS's, Elizabeth Crystal, Joe Rogan, didn't, Jesus Christ, Crystal, Meaghan Buisson, Richard Yensen, Donna, Yensen, Buisson, weren't, Robert, Rebekah Mercer, Sean Zanni, Grof, They've, Kayla Greenstien, it's, George Sarlo who'd, Vicky Dulai, Sarlo's, Dulai, Gul Dolen, Michael Mullette, who'd, Marla Aufmuth, Mullette, Lily Kay Ross, David Nickles, Ross, Greenstien, Rick, Lenny Ignelzi, biostatisticians, Lykos, Peter Thiel, Kara Swisher, Kris Lotlikar, Federico Menapace, Mo Septimus, Handout, Monnica, Williams, Lotlikar, Henry Elkus, Helena ., Elkus, Emerson, ICER Organizations: Science, New York Jets, rockstar, Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, and Drug Administration, FDA, Business, Florida's New College, Jewish Telegraphic Agency, Sarasota Herald, Tribune, New College, Guardian, Drug, Harvard's Kennedy School of Government, eBay, Nevada, Doblin, Pentagon, Department of Veterans Affairs, Department of Defense, Staff, Corporation, PBC, pharma, New Yorker, New York Mets, Bloomberg, CBS, Breitbart, CBC News, BI, Porsche, Santa Cruz, New York Times, longtime, Mullette Corporation, New York, Health Canada, Compass, Sciences, Psychedelic Science, Whole Foods, McKinsey, Big Pharma, Vine Ventures, Lucid, Street Journal, Investments, Gawker, Publicly, PBC alums, Numinus, US Army Locations: Patagonia, Denver, Harvard, Colorado, Skokie , Illinois, Ireland, Czech, Sarasota, Arcturus, Florida, Swiss, Vietnam, Washington, Santa Cruz, Chicago, California, Iraq, British Columbia, New York, Hawaii, Santa, Nature, Moderna, Europe, Helena, Yale, Australia, Canada, Israel, Ukraine, ICER, . Upper

☆ Elon Musk Isn't the Only One Using Drugs As a Work Performance Boost
▼ + stars: | 2024-03-24 | by ( Emily Stewart | ) www.businessinsider.com time to read: +11 min

You could get a mushroom that has a little bit more or a little bit less psilocybin ... which, depending on the activity of the day, might be more than you bargained for. Some corporate elites are seeking out psychedelic retreats to improve their leadership skills, shift their perceptions, and, in some cases, even bond with their teams. My main concern is that people understand the risk, any risk — bad-trip risk, psychiatric risk, or legal risk. "My main concern is that people understand the risk, any risk — bad-trip risk, psychiatric risk, or legal risk," Johnson said. A lot of executives and workers have a little bit of Elon Musk in them.

Persons: Elon, he's, Musk, à, Steve Jobs, they're, Greg Fonzo, Matthew Johnson, Sheppard Pratt, hasn't, Johnson, It's, Katrina Michelle, Rob Grover, Gary Logan, Grover, that's, Michelle, Justin Townsend, it's, performancewise, Townsend, Emily Stewart Organizations: SpaceX, Twitter, Center for Psychedelic Research, University of Texas, Austin's Dell Medical School, Center, Multidisciplinary Association for Psychedelic Studies, Marijuana, Elon Musk, Business Locations: New York, Vancouver , British Columbia, Jamaica

☆ Maker of MDMA-assisted PTSD treatment to seek US regulatory nod
▼ + stars: | 2023-09-15 | by ( ) www.reuters.com time to read: +2 min

A woman retrieves items from the rubble of her destroyed home after a wildfire came through the area in Talent, Oregon, Oregon, U.S. September 21, 2020. PTSD is a disorder caused by very stressful events and can significantly disrupt patients' lives. While PTSD is commonly associated with combat, civilians are not immune to it. Psychoactive ingredients, whether derived from cannabis, LSD or magic mushrooms, have long captivated mental health researchers in their quest for treatments. MAPS, founded in 1986, said it hopes the MDMA-assisted therapy will be approved next year and inspire other researchers studying therapeutic psychedelics.

Persons: Jim Urquhart, Manas Mishra, Pooja Desai Organizations: REUTERS, Multidisciplinary Association for Psychedelic Studies, U.S . Food, Drug Administration, Thomson Locations: Talent , Oregon , Oregon, U.S, United States, Bengaluru

The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. “It’s the first innovation in PTSD treatment in more than two decades. Political Cartoons View All 1160 ImagesCommon side effects in the MDMA group were muscle tightness, nausea, decreased appetite and sweating. But only one person in the MDMA group dropped out of the study. After treatment, 86% of the MDMA group improved on a standard PTSD assessment compared to 69% of the placebo group.

Persons: ”, Amy Emerson, Barbara Rothbaum, ” Rothbaum Organizations: Corporation, Multidisciplinary, for Psychedelic Studies, Emory Healthcare Veterans Program, Nature, Food and Drug Administration, Drug, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: Australia, U.S, Atlanta

☆ VC Ford Smith used psychedelics and biohacking to pull himself out of a deep depression. Here's why he's backing more startups in the space.
▼ + stars: | 2023-09-07 | by ( Samantha Stokes | ) www.businessinsider.com time to read: +7 min

His experience inspired him to focus his investment firm on backing psychedelic startups. But VCs, including Smith, are still betting big on startups in the space that seem especially promising. It wasn't until he tried psychedelics — including Ayahuasca, a plant-derived hallucinogenic drink, and iboga, an African root bark — that his mental health finally improved. Energized by his own experience, Smith reworked his cannabis-focused VC firm Ultranative into a one-stop-shop for psychedelic startups. Smith and Ultranative are far from the only investors pumping money into psychedelic startups.

Persons: Ford Smith, wean, South America —, Ayahuasca, Ultranative, Smith, didn't, Lyme, psychedelics, Rick Doblin, he's Organizations: innovating, Venture, Anonymous, Multidisciplinary Association for Psychedelic Studies, pharma, FDA, PsyMed Ventures, Lionheart Ventures, Iter Investments, Neo Kuma Ventures, Therapeutics Locations: Austin, South America, U.S, Oregon, Colorado, psychedelics, Texas, Los Angeles, Massachusetts

☆ Here's what MDMA does to your brain and body
▼ + stars: | 2023-03-06 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +2 min

One organization has been testing MDMA for decades to see if it could be helpful for patients with post traumatic stress disorder. As MDMA inches closer to becoming an approved medicine, Insider put together a step-by-step look at how MDMA affects the body and brain. In MAPS' trials, participants take MDMA during a supervised experience. This is typically when they tend to talk more about the insight they've gained throughout their experience. At around the eight hour mark, they're typically done with the session and ready to relax.

Hundreds of experiments are in progress worldwide, examining psychedelics' potential as medicines. Insider identified 22 key trials that could make or break the psychedelics industry's future. If they succeed, these trials could pave the way for psychedelics to be used as medical treatments. Hundreds of clinical trials are underway worldwide, examining the potential of psychedelics as treatments for health conditions, including post-traumatic stress disorder, severe depression, and anorexia. The total market for psychedelics-related medicines could eventually reach $100 billion, according to a 2020 report from Tania Gonsalves at Canaccord Genuity.

☆ How a family's struggle to help their son gave rise to controversial $400 million psychedelics giant Compass Pathways
▼ + stars: | 2023-02-15 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +18 min

Today, Compass Pathways, the for-profit company they launched in 2016, is a Nasdaq-listed firm worth about $400 million. Compass Pathways Show lessIt could also boost the dozens of psychedelics companies inspired by Compass that have been formed in recent years. Insider spoke with more than a dozen industry participants to chart the rise of Compass Pathways and its role in the psychedelics boom. He recalled the 2018 Quartz article that detailed the growing alarm around Compass Pathways' "magic mushroom monopoly." Were it not for his decision to take a break from college, and his parents' efforts to find a treatment, Compass Pathways might not exist.

☆ Psychedelic therapies are on the horizon. Who will administer them?
▼ + stars: | 2022-12-26 | by ( Danica Jefferies | Danica Jefferies Is An Intern With The Data Graphics Team For Nbc News Digital. | ) www.nbcnews.com time to read: +11 min

Psychedelic therapy is nowhere near as simple as filling a prescription and taking a pill at home. A clinical psychologist, she founded and now leads the first accredited psychedelic therapy training program in the U.S. at the California Institute of Integral Studies. The psychedelic therapy program entails 150 hours of instruction and several in-person training sessions. So why the growing interest in using psychedelic drugs for mental health? Treatment with psychedelic drugs is not as simple as giving the patient a pill to take at home, and it’s not for everybody.

☆ Trump's most important 2016 donor is sitting out 2020
▼ + stars: | 2020-07-24 | by ( Dave Levinthal | ) www.businessinsider.com time to read: +20 min

Robert and Rebekah Mercer ranked among President Donald Trump's most influential backers in 2016. A representative for Priorities USA Action, a leading pro-Biden super PAC, said the organization wasn't underestimating Trump's reelection forces, Mercers or no Mercers. (Bossie, like former Trump campaign manager Corey Lewandowski and many others, has recently found himself back in Trump's favor.) The Cambridge Analytica data that the Trump campaign paid for was "so stupidly wrong" and a "complete joke," Spicer added. But sources familiar with the Mercers' political spending said they have no evidence that the Mercers are doing so.

Search resuls for: "Multidisciplinary Association for Psychedelic Studies"

10 mentions found